BH3 profiling of the HNSCC cell lines and targeted treatment experiments using a BCL-XL-mimetic will perhaps further elucidate the mechanism of resistance to AZD-5991. The gene discussed is BCL2L1; the disease is head and neck squamous cell carcinoma.